Evidence map›Paper›PMID 27590742›Full record

ArticleDrug and alcohol dependence2016

A contingency management method for 30-days abstinence in non-treatment seeking young adult cannabis users.

Randi Melissa Schuster, Ailish Hanly, Jodi Gilman, Alan Budney, Ryan Vandrey, A Eden Evins

Open access · greenAbstract read
In one paragraph

Article in Drug and alcohol dependence, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 2 pooled it
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 2 syntheses or guidelines pooled it, 34 citations in OpenAlex.

  1. Pooled it
  2. A scoping review and meta-analysis of psychosocial and pharmacological treatments for cannabis and tobacco use among African Americans.Psychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors · 2017
    Pooled it
  3. N-acetylcysteine for youth cannabis use disorder: randomized controlled trial main findings.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2025
    Trial
  4. Trial
  5. Trial
  6. Alcohol substitution during one month of cannabis abstinence among non-treatment seeking youth.Progress in neuro-psychopharmacology & biological psychiatry · 2021
    Trial
  7. Trial
  8. Trial
  9. Pharmacotherapy for Cannabis Use Disorder: Preclinical and Clinical Models.Current topics in behavioral neurosciences · 2026
    Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Cannabis use and cannabis use disorder.Nature reviews. Disease primers · 2021
    Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Randi Melissa SchusterCenter for Addiction Medicine, Department of Psychiatry, Massachusetts General Hospital (MGH) Boston, MA, USA; Harvard Medical School, Boston, MA, USA. Electronic address: rschuster@mgh.harvard.edu.
Ailish HanlyCenter for Addiction Medicine, Department of Psychiatry, Massachusetts General Hospital (MGH) Boston, MA, USA.
Jodi GilmanCenter for Addiction Medicine, Department of Psychiatry, Massachusetts General Hospital (MGH) Boston, MA, USA; Harvard Medical School, Boston, MA, USA.
Alan BudneyDartmouth College, Geisel School Of Medicine, Lebanon NH, USA.
Ryan VandreyJohns Hopkins University School of Medicine, Baltimore, MD, USA.
A Eden EvinsCenter for Addiction Medicine, Department of Psychiatry, Massachusetts General Hospital (MGH) Boston, MA, USA; Harvard Medical School, Boston, MA, USA.
Massachusetts General Hospital · USDartmouth College · USHarvard University · USJohns Hopkins University · US

Funding

Treatment Development & Evaluation CoreP30DA029926 · NIDA · DARTMOUTH COLLEGE · PI Lisa A. Marsch · 2011 to 2026
$21.5M
Medical Marijuana, Neurocognition, and Subsequent Substance UseR01DA042043 · NIDA · MASSACHUSETTS GENERAL HOSPITAL · PI GILMAN, JODI · 2017 to 2021
$3.3M
Role of Sleep in the Treatment of Cannabis DependenceU01DA031784 · NIDA · JOHNS HOPKINS UNIVERSITY · PI VANDREY, RYAN G · 2012 to 2016
$3.2M
Mentoring in Addiction Treatment ResearchK24DA030443 · NIDA · MASSACHUSETTS GENERAL HOSPITAL · PI EVINS, A EDEN · 2010 to 2020
$2.0M
Neurobehavioral Characterization of Social Influence in Drug AddictionK01DA034093 · NIDA · MASSACHUSETTS GENERAL HOSPITAL · PI GILMAN, JODI · 2013 to 2017
$925k
NIDA NIH HHS K01 DA034093NIDA NIH HHS K24 DA030443NIDA NIH HHS P30 DA029926NIDA NIH HHS R01 DA042043NIDA NIH HHS U01 DA031784
6 · The paper itself

Abstract

backgroundRates of young adult cannabis use are rising, perceived harm is at its historical nadir, and most users do not want to quit. Most studies evaluating effects of cannabis use in young adults are cross-sectional, limiting causal inference. A method to reliably induce abstinence periods in cannabis users would allow assessment of the effects of abstinence and resumption of use on a variety of outcomes in a within-subjects, repeated measures design.

methodsWe examined the efficacy and feasibility of a voucher-based contingency management procedure for incentivizing one month of continuous cannabis abstinence among young adults who reported at least weekly cannabis use, volunteered to participate in a laboratory study, and did not express a desire to discontinue cannabis use long-term. Continuous cannabis abstinence was reinforced with an escalating incentive schedule, and self-report of abstinence was confirmed by frequent quantitative assays of urine cannabis metabolite (THCCOOH) concentration. New cannabis use during the abstinence period was determined using an established algorithm of change in creatinine-adjusted cannabis metabolite concentrations between study visits.

resultsThirty-eight young adults, aged 18-25 years, enrolled and 34 (89.5%) attained biochemically confirmed 30-day abstinence. Among those who attained abstinence, 93.9% resumed regular use within two-weeks of incentive discontinuation.

conclusionFindings support the feasibility and efficacy of contingency management to elicit short-term, continuous cannabis abstinence among young adult, non-treatment seeking, regular cannabis users. Further work should test the effectiveness of this contingency management procedure for cannabis abstinence in periods longer than one month, which may be required to evaluate some effects of abstinence.

Indexed as

Behavior TherapyMotivationAdolescentAdultCross-Sectional StudiesFeasibility StudiesFemaleHumansMaleMarijuana AbuseMarijuana SmokingTreatment OutcomeYoung AdultAbstinenceCannabisContingency managementMarijuanaMethodologyYoung adults

Identifiers

PMID27590742
PMCPMC5235346
OpenAlexW2507870283

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.